Literature DB >> 7829086

Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171.

L A Cannon-Albright1, D E Goldgar, S Neuhausen, N A Gruis, D E Anderson, C M Lewis, M Jost, T D Tran, K Nyguen, A Kamb.   

Abstract

A familial melanoma susceptibility locus (MLM) was identified on the short arm of chromosome 9 in a set of Utah and Texas kindreds. Subsequent confirmation was reported for a set of 26 Australian kindreds, a set of 7 Dutch kindreds, and a set of 13 NIH melanoma kindreds. The original localization report placed the locus near the IFNA-D9S126 interval on chromosome 9p. We report further localization using D9S171 and a newly developed marker, D9S736, both of which lie in the IFNA-D9S126 interval. Analysis of this set of kindreds places the melanoma susceptibility locus in a 2-cM region that is proximal to D9S736 and distal to D9S171.

Entities:  

Mesh：

Year:  1994        PMID： 7829086     DOI： 10.1006/geno.1994.1491

Source DB:  PubMed          Journal:  Genomics        ISSN： 0888-7543            Impact factor:   5.736


  10 in total

1.  Evaluation for Kienböck Disease Familial Clustering: A Population-Based Cohort Study.

Authors:  Nikolas H Kazmers; Zhe Yu; Tyler Barker; Tyler Abraham; Robin Romero; Michael J Jurynec
Journal:  J Hand Surg Am       Date:  2019-11-22       Impact factor: 2.230

2.  Diaphyseal medullary stenosis with malignant fibrous histiocytoma: a hereditary bone dysplasia/cancer syndrome maps to 9p21-22.

Authors:  J A Martignetti; R J Desnick; E Aliprandis; K I Norton; P Hardcastle; S Nade; B D Gelb
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

3.  Mapping autosomal dominant progressive limb-girdle myopathy with bone fragility to chromosome 9p21-p22: a novel locus for a musculoskeletal syndrome.

Authors:  Giles D J Watts; Sarju G Mehta; Chengfeng Zhao; Sheena Ramdeen; Sara Jane Hamilton; Deborah V Novack; Steven Mumm; Michael P Whyte; Barbara Mc Gillivray; Virginia E Kimonis
Journal:  Hum Genet       Date:  2005-10-22       Impact factor: 4.132

4.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

5.  Familial Clustering of Erosive Hand Osteoarthritis in a Large Statewide Cohort.

Authors:  Nikolas H Kazmers; Huong D Meeks; Kendra A Novak; Zhe Yu; Gail L Fulde; Joy L Thomas; Tyler Barker; Michael J Jurynec
Journal:  Arthritis Rheumatol       Date:  2021-01-29       Impact factor: 10.995

6.  p16(INK4A) positively regulates p21(WAF1) expression by suppressing AUF1-dependent mRNA decay.

Authors:  Huda H Al-Khalaf; Abdelilah Aboussekhra
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

7.  CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.

Authors:  Hui Deng; Jing Liu; Yu Deng; Gangwen Han; Yiqun G Shellman; Steven E Robinson; John J Tentler; William A Robinson; David A Norris; Xiao-Jing Wang; Qinghong Zhang
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551

8.  A population-based analysis of clustering identifies a strong genetic contribution to lethal prostate cancer.

Authors:  Quentin Nelson; Neeraj Agarwal; Robert Stephenson; Lisa A Cannon-Albright
Journal:  Front Genet       Date:  2013-08-20       Impact factor: 4.599

9.  Genetic analysis of low BMI phenotype in the Utah Population Database.

Authors:  William R Yates; Craig Johnson; Patrick McKee; Lisa A Cannon-Albright
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

10.  Management of melanoma families.

Authors:  Wilma Bergman; Nelleke A Gruis
Journal:  Cancers (Basel)       Date:  2010-04-16       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.